Dr. Eng is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2220 Pierce Avenue, 777 PRB
Nashville, TN 37232Phone+1 615-322-5000- Is this information wrong?
Summary
- Dr. Cathy Eng is an oncologist in Nashville, TN and is affiliated with Vanderbilt-Ingram Cancer Center. She received her medical degree from Drexel University College of Medicine/Hahnemann University and has been in practice 23 years. She specializes in gastrointestinal cancer clinical research.
Education & Training
- University of ChicagoFellowship, Hematology and Medical Oncology, 1999 - 2002
- Rush University Medical CenterResidency, Internal Medicine, 1996 - 1999
- Rutgers Health/Cooperman Barnabas Medical CenterResidency, Radiology-Diagnostic, 1995 - 1996
- Drexel University College of Medicine/Hahnemann University HospitalInternship, Internal Medicine, 1994 - 1995
- Drexel University College of MedicineClass of 1994
Certifications & Licensure
- TX State Medical License 2002 - 2026
- IL State Medical License 1996 - 2026
- TN State Medical License 2019 - 2025
- AL State Medical License 2020 - 2020
- NJ State Medical License 1995 - 1997
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- White House Cancer Moonshot Colorectal Cancer Panel: Colorectal Cancer Treatment, Innovation and support White House, 2023
- Fellow Hedwig van Ameringen Executive Leadership in Academic Medicine, 2022
- Regional Top Doctor Castle Connolly, 2009-2022
- Join now to see all
Clinical Trials
- Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer Start of enrollment: 2004 Apr 01
- S0408: Capecitabine, Oxaliplatin, and Bevacizumab in Pts Undergoing Surgery for Liver Mets From Colorectal Cancer Start of enrollment: 2006 Nov 01
- Prognostic Molecular and Environmental Factors in High-Risk Colon Cancer Patients Start of enrollment: 2006 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- CLO24-088: Efficacy of Fruquintinib in Less Heavily Pretreated Patients (Pts) With Metastatic Colorectal Cancer (mCRC): Profile-Matched Data From FRESCO and FRESCO-2.Arvind Dasari, Cathy Eng, Sara Lonardi, Rocio Garcia-Carbonero, Toshiki Masuishi, Chiara Cremolini, Francois Ghiringhelli, Joleen Hubbard, Tanios Bekaii-Saab, Jeremy J...> ;Journal of the National Comprehensive Cancer Network. 2024 Apr 5
- Data-driven optimization of version 9 American Joint Committee on Cancer staging system for anal cancer.Browner, A., Cotler, J., Nelson, H., Ballman, K., LeBlanc, M., Brierley, J., Goldberg, R., Washington, M., Palis, B., Janczewski, L., Gollub, M., Eng, C., Palefsky, J....> ;Cancer. 2023 Dec 22
- Mutational Signature Changes in Patients With Metastatic Squamous Cell Carcinoma of the Anal Canal.Michael LaPelusa, Christopher Cann, Kristen K Ciombor, Cathy Eng> ;The Oncologist. 2024 Apr 4
- Join now to see all
Journal Articles
- Spectrum of Somatic Cancer Gene Variations Among Adults with Appendiceal Cancer by Age at Disease OnsetCathy Eng, MD, JAMA Network Open
Press Mentions
- Using an Algorithm to Determine the Right Colon Cancer TreatmentMay 9th, 2023
- Colorectal Cancer in Young PeopleMarch 21st, 2023
- Study Shows Inherited Risk Factors for Appendiceal CancerNovember 11th, 2022
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
- Vanderbilt University Medical CenterNashville, Tennessee
External Links
- LinkedInhttp://www.linkedin.com/in/cathy-eng-18b23b89
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: